Babesia microti tests approved by FDA for screening blood, organ and tissue donors
by Press Release from Outbreak News Today on (#3HH18)
The U.S. Food and Drug Administration today approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay (AFIA), for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples. These tests are intended to be used as donor screening tests on samples ["]
The post Babesia microti tests approved by FDA for screening blood, organ and tissue donors appeared first on Outbreak News Today.